Related Experiment Video
Updated: Jun 17, 2026

10:08
Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
12.2K
Plasmonics-Enhanced Characterization of Cervid PrP (87-114) Fragment Aggregates in Solution
Shinki Midha1, Aishwarya Sriraman2,3, Lyudmyla Dorosh1
1Department of Electrical and Computer Engineering, University of Alberta, Canada.
Journal of Biophotonics
|November 26, 2025
Summary
Researchers characterized prion protein aggregates linked to chronic wasting disease (CWD) using advanced spectroscopy. This study reveals key spectral markers indicating fibril formation in prion disease research.
Area of Science:
- Biochemistry
- Biophysics
- Neuroscience
Background:
- The white-tailed deer (WTD) prion protein (PrP) residue 87-114 fragment is implicated in chronic wasting disease (CWD) pathogenesis.
- Understanding the structural conversion of PrP is crucial for CWD transmission research in cervids.
Purpose of the Study:
- To characterize the self-assembled fibrillar aggregates of the WTD PrP (87-114) fragment.
- To investigate peptide aggregation using multimodal characterization techniques under ambient conditions.
Main Methods:
- Utilized plasmon-enhanced bright-field microscopy for imaging.
- Employed label-free surface-enhanced Raman spectroscopy (SERS) for molecular analysis.
- Incorporated Thioflavin T staining to assess fibril formation.
Main Results:
- Observed a transition from dispersed states to well-defined fibrillar networks.
- Detected spectral evolution in backbone-sensitive SERS bands during aggregation.
- Identified amide III and tryptophan vibrational features as indicators of fibrillar architecture in SERS.
Conclusions:
- Established specific SERS spectral features indicative of prion protein fibril formation.
- Provided insights into the aggregation behavior of amyloidogenic sequences relevant to CWD susceptibility.
- Demonstrated the utility of integrated plasmonic substrates for multimodal characterization of protein aggregation.

